Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitral valve prolapse. When is it serious?

T O Cheng1

  • 1George Washington University Medical Center, Washington, DC 20037.

Postgraduate Medicine
|November 15, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-to-benefit ratio of Swan-Ganz catheterization.

AJR. American journal of roentgenology·1997
Same author

Ventricular aneurysm and coronary artery disease: the hen and the egg?

Catheterization and cardiovascular diagnosis·1997
Same author

Mitral valve prolapse secondary to rheumatic valvulitis.

International journal of cardiology·1997
Same author

Underuse of warfarin in atrial fibrillation.

Archives of internal medicine·1997
Same author

What is ESMIR?

The American journal of cardiology·1997
Same author

Hypertrophic obstructive cardiomyopathy: alternative therapeutic options.

Clinical cardiology·1997
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles

Mitral valve prolapse is diagnosed through clinical evaluation and dynamic auscultation. Treatment involves reassurance, symptom management, and monitoring for complications, most of which are preventable or treatable.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Mitral valve prolapse (MVP) is a common cardiac condition.
  • Accurate diagnosis and management are crucial for patient outcomes.

Purpose of the Study:

  • To outline the optimal diagnostic and therapeutic strategies for mitral valve prolapse.
  • To emphasize the importance of clinical evaluation and complication monitoring.

Main Methods:

  • Diagnosis relies on thorough clinical assessment.
  • Dynamic auscultation is a key diagnostic tool.
  • Management includes reassurance, pharmacotherapy, and vigilant monitoring.

Main Results:

  • Careful clinical evaluation, including dynamic auscultation, is the cornerstone of MVP diagnosis.

Related Experiment Videos

  • Pharmacotherapy can effectively manage symptomatic cases.
  • Proactive monitoring allows for the prevention or timely treatment of complications.

    • Conclusions:

    • Mitral valve prolapse diagnosis is best achieved through expert clinical evaluation.
    • Effective management strategies exist for symptoms and complications of MVP.
    • Most complications associated with mitral valve prolapse can be successfully managed.